Literature DB >> 8157752

Phase contrast microscopic examination of urinary erythrocytes to localise source of bleeding: an overlooked technique?

K S Mohammad1, A S Bdesha, M E Snell, R O Witherow, D V Coleman.   

Abstract

AIMS: To localise the source of bleeding in the urinary tract in patients presenting with haematuria.
METHODS: Urine samples were obtained from 109 patients with symptoms referable to the urinary tract. The sample was examined for the presence of red blood cells by phase contrast microscopy (PCM) and the proportion of dysmorphic and isomorphic red blood cells was determined. If more than 20% of the red blood cells were dysmorphic a glomerular origin for the site of bleeding was suspected; if less than 20% of the red blood cells were isomorphic a non-glomerular origin was suspected. Phase contrast microscopy and clinical findings were correlated.
RESULTS: The correct bleeding site was shown in 27 of 30 (90%) patients with glomerulopathy and in all 17 patients with bleeding from the lower urinary tract, indicating that this method of analysis has a sensitivity of 90% and specificity of 100% for detecting the glomerular source of bleeding.
CONCLUSIONS: The examination of urine for dysmorphic and isomorphic red blood cells by phase contrast microscopy is strongly recommended in routine clinical practice for the detection of glomerular and non-glomerular lesions. This technique may avoid unnecessary investigations for the diagnosis of the site of bleeding in patients with haematuria.

Entities:  

Mesh:

Year:  1993        PMID: 8157752      PMCID: PMC501394          DOI: 10.1136/jcp.46.7.642

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Microhaematuria in general practice: is urine microscopy misleading?

Authors:  A C Dowell; J P Britton
Journal:  Br J Gen Pract       Date:  1990-02       Impact factor: 5.386

2.  Haematuria: glomerular or non-glomerular?

Authors:  D F Birch; K F Fairley
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

3.  Value of urinary erythrocyte morphology in assessment of symptomless microhaematuria.

Authors:  P Schramek; F X Schuster; M Georgopoulos; P Porpaczy; M Maier
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

4.  Usefulness of urinary red-cell morphology examination.

Authors:  F Braggion; G Rizzoni
Journal:  Nephron       Date:  1988       Impact factor: 2.847

5.  A blind controlled trial of phase-contrast microscopy by two observers for evaluating the source of haematuria.

Authors:  G Venkat Raman; L Pead; H A Lee; R Maskell
Journal:  Nephron       Date:  1986       Impact factor: 2.847

6.  Differentiation of renal from non-renal hematuria by microscopic examination of erythrocytes in urine.

Authors:  T J Pillsworth; V M Haver; C K Abrass; C J Delaney
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

7.  Diagnostic value of phase contrast microscopy in haematuria.

Authors:  M B Abdurrahman; A M Kambal; K M Kurbaan; M Y Imambaccus; A H Chagla
Journal:  Trop Geogr Med       Date:  1985-06

8.  Detection of glomerular bleeding by phase-contrast microscopy.

Authors:  R G Fassett; B A Horgan; T H Mathew
Journal:  Lancet       Date:  1982-06-26       Impact factor: 79.321

9.  Localisation of haematuria by red cell analysers and phase contrast microscopy.

Authors:  M P de Caestecker; C L Hall; P T Basterfield; J G Smith
Journal:  Nephron       Date:  1989       Impact factor: 2.847

  9 in total
  2 in total

1.  Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective.

Authors:  Kyo Chul Koo; Kwang Suk Lee; Ah Ran Choi; Koon Ho Rha; Sung Joon Hong; Byung Ha Chung
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

2.  Dysmorphic erythrocytes are superior to hematuria for indicating non-diabetic renal disease in type 2 diabetics.

Authors:  Zhe-yi Dong; Yuan-da Wang; Qiang Qiu; Kai Hou; Li Zhang; Jie Wu; Han-yu Zhu; Guang-yan Cai; Xue-feng Sun; Xue-guang Zhang; Mo-yan Liu; Jia Kou; Xiang-mei Chen
Journal:  J Diabetes Investig       Date:  2015-06-11       Impact factor: 4.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.